Inhibition of Heme Oxygenase-1 Enhances the Cytotoxic Effect of Gemcitabine in Urothelial Cancer Cells

被引：0

作者：

Miyake, Makito ^{[1
]}

Fujimoto, Kiyohide ^{[1
]}

Anai, Satoshi ^{[1
]}

Ohnishi, Sayuri ^{[1
]}

Nakai, Yasushi ^{[1
]}

Inoue, Takeshi ^{[1
]}

Matsumura, Yoshiaki ^{[1
]}

Tomioka, Atsushi ^{[1
]}

Ikeda, Tomohiro ^{[1
]}

Okajima, Eijiro ^{[1
]}

Tanaka, Nobumichi ^{[1
]}

Hirao, Yoshihiko ^{[1
]}

机构：

[1] Nara Med Univ, Dept Urol, Nara 6348522, Japan

来源：

ANTICANCER RESEARCH | 2010年 / 30卷 / 06期

关键词：

Urothelial cancer; heme oxygenase-1; drug resistance; chemotherapy; radiotherapy; gemcitabine; PEGYLATED ZINC PROTOPORPHYRIN; PHASE-II TRIAL; PANCREATIC-CANCER; PLUS CISPLATIN; GENE-EXPRESSION; PROSTATE-CANCER; BLADDER-CANCER; IN-VITRO; THERAPY; CARCINOMA;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background: Elevated heme oxygenase-1 (HO-1) is associated with resistance to chemo- and radiotherapy through anti-apoptotic function. The present study evaluated whether the HO-I inhibitor, zinc protoporphyrin IX (ZnPP), enhances the cytotoxic effect of gemcitabine in urothelial carcinoma (UC). Materials and Methods: The in vitro cytotoxic effect of combination treatment of gemcitabine and ZnPP on UC cells was examined. The in vivo growth inhibitory effects of intraperitoneal administration of gemcitabine and/or ZnPP on mouse subcutaneous tumours were examined. The apoptotic changes were analysed with the detection of DNA fragmentation and cleaved caspase-3. Results: HO-I was up-regulated by both gemcitabine and irradiation treatment in vitro. ZnPP sensitised the UC cells to both therapies. Enhanced apoptosis was induced by the ZnPP combined with gemicitabine. ZnPP enhanced the antitumour effect of gemcitabine in vivo along with decreased numbers of proliferating cells and increased numbers of apoptotic cells. Conclusion: These findings suggest that ZnPP combined with gemcitabine or irradiation therapy may be an effective therapeutic modality for UC patients.

引用

页码：2145 / 2152

页数：8

共 30 条

[21] Zinc protoporphyrin IX, a heme oxygenase-I inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in mice
Nowis, Dominika
Bugajski, Marek
Winiarska, Magdalena
Bil, Jacek
Szokalska, Angelika
Salwa, Pawel
Issat, Tadeusz
Was, Halina
Jozkowicz, Alicja
Dulak, Jozef
Stoklosa, Tomasz
Golab, Jakub
[J]. BMC CANCER, 2008, 8 (1)
[22] PETERS GJ, 1995, SEMIN ONCOL, V22, P72
[23] Molecular basis of heme oxygenase-1 induction: Implications for chemoprevention and chemoprotection
Prawan, A
Kundu, JK
Surh, YJ
[J]. ANTIOXIDANTS & REDOX SIGNALING, 2005, 7 (11-12) : 1688 - 1703
[24] Systemic chemotherapy for advanced non-small cell lung cancer: Recent advances and future directions
Ramalingam, Suresh
Belani, Chandra
[J]. ONCOLOGIST, 2008, 13 : 5 - 13
[25] Nuclear translocation of haeme oxygenase-1 is associated to prostate cancer
Sacca, P.
Meiss, R.
Casas, G.
Mazza, O.
Calvo, J. C.
Navone, N.
Vazquez, E.
[J]. BRITISH JOURNAL OF CANCER, 2007, 97 (12) : 1683 - 1689
[26] Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging
Sugano, Kokichi
Kakizoe, Tadao
[J]. NATURE CLINICAL PRACTICE UROLOGY, 2006, 3 (12): : 642 - 652
[27] Chemoradiotherapy as a bladder-preservation approach for muscle-invasive bladder cancer: Current status and perspectives
Sumiyoshi Y.
[J]. International Journal of Clinical Oncology, 2004, 9 (6) : 484 - 490
[28] von der Maase H, 2005, J CLIN ONCOL, V23, P4602, DOI 10.1200/JCO.2005.07.757
[29] Weekly gemcitabine and cisplatin combination therapy in patients with transitional cell carcinoma of the urothelium:: A phase II clinical trial
von der Maase, H
Andersen, L
Crinò, L
Weinknecht, S
Dogliotti, L
[J]. ANNALS OF ONCOLOGY, 1999, 10 (12) : 1461 - 1465
[30] Yi Sun K, 2007, Pain Physician, V10, P285

← 1 2 3 →